Testing effectiveness (Phase 2)Ended earlyNCT00400205What this trial is testingStudy of Induction Docetaxel, Cisplatin and 5-FluorouracilWho this might be right forSquamous Cell CarcinomaOral Cancer Emory University 14
Testing effectiveness (Phase 2)Ended earlyNCT01313390What this trial is testingEverolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Not applicableNot Yet RecruitingNCT06328868What this trial is testingMultifunctional Nutrition Tube in Dysphagia for Nasopharyngeal CarcinomaWho this might be right forDysphagia Copka Sonpashan 80
Not applicableUnknownNCT00983697What this trial is testingFDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N CancerWho this might be right forHead and Neck Cancer American College of Radiology Imaging Network 292
Early research (Phase 1)Study completedNCT00478725What this trial is testingPart A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034Who this might be right forCarcinoma, Renal Cell GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT00826878What this trial is testingAn Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung AVEO Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03370276What this trial is testingCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more H. Lee Moffitt Cancer Center and Research Institute 95
Early research (Phase 1)Ended earlyNCT01283178What this trial is testingPhase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCWho this might be right forSalivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Hypopharynx+13 more Virginia Commonwealth University 3
Large-scale testing (Phase 3)Study completedNCT00002476What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Cancer Research UK
Not applicableStudy completedNCT02981862What this trial is testingCaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating CarcinomasWho this might be right forCervical CancerVulvar CancerAnal Cancer+3 more Institut de Cancérologie de Lorraine 100
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT02381535What this trial is testingOnalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinWho this might be right forStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more National Cancer Institute (NCI) 2
Large-scale testing (Phase 3)WithdrawnNCT04129320What this trial is testingEnoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck CancerSquamous Cell Carcinoma of Head and Neck MacroGenics
Very early researchEnded earlyNCT01587820What this trial is testingIntra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx CancerWho this might be right forHead and Neck Cancer Southern Illinois University 1
Large-scale testing (Phase 3)UnknownNCT00022373What this trial is testingIseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerOral Complications of Radiation TherapyRadiation Toxicity National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01695122What this trial is testingValproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck CancerOral Cavity CancerOropharyngeal Cancer Instituto do Cancer do Estado de São Paulo 14
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT01096381What this trial is testingPotential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorWho this might be right forBreast CancerCardiovascular ComplicationsColorectal Cancer+6 more Vanderbilt-Ingram Cancer Center 8
Not applicableLooking for participantsNCT05375266What this trial is testingImmune Biomarker Study for Head and Neck CancerWho this might be right forHead and Neck CancerOral Cavity CancerOropharyngeal Cancer+2 more University of Erlangen-Nürnberg Medical School 1,100